← EPO Patent Bulletin

OLIGONUCLEOTIDES TARGETED TO PNPLA3 FOR USE IN A METHOD OF TREATING A LIVER DISEASE

Publication EP4045062A1 Kind: A1 Mar 18, 2026

Applicants

Astrazeneca AB

Inventors

LINDEN, Daniel

IPC Classifications

A61K 31/713 20060101AFI20250115BHEP C12N 15/00 20060101ALI20250115BHEP A61P 1/16 20060101ALI20250115BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR